Working to advance the development of vaccines and vaccination for the advancement of global health and disease elimination and eradication globally. IEPI works with our partners to investigate ways to safely involve human subjects in clinical research, especially those typically defined as vulnerable populations.
Azithromycin for All-Cause Mortality: Azithromycin has inadvertently been shown to lower all-cause mortality in a clinical trial evaluating blinding trachoma. IEPI is providing advisory support on the moral imperative of utilizing azithromycin off-label to potentially lower all-cause mortality.
Adaptive Clinical Trials